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Plaque psoriasis is a chronic inflammatory disorder of the skin. It is inherited as a multifactorial trait, with a
strong genetic component. Linkage studies have identified a large number of disease loci, but very few could be
replicated in independent family sets. In this study, we present the results of a genome-wide scan carried out in
14 French extended families. Candidate regions were then tested in a second set of 32 families. Analysis of the
pooled samples confirmed linkage to chromosomes 6p21 (ZMLB score¼ 3.5, P¼ 0.0002) and 20p13 (ZMLB
score¼ 2.9, P¼ 0.002), although there was little contribution of the second family set to the 20p13 linkage signal.
Moreover, we identified four additional loci potentially linked to psoriasis. The major histocompatibility
complex region on 6p21 is a major susceptibility locus, referred to as PSORS1, which has been found in most of
the studies published to date. The 20p13 locus segregates independently of PSORS1 in psoriasis families. It has
previously been thought to be involved in the predisposition to psoriasis and other inflammatory disorders
such as atopic dermatitis (AD) and asthma. Although psoriasis and AD rarely occur together, this reinforces the
hypothesis that psoriasis is influenced by genes with general effects on inflammation and immunity.
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INTRODUCTION
Psoriasis is a chronic inflammatory dermatosis that affects
2–4% of the Caucasian population (Nevitt and Hutchinson,
1996). Clinically, the disorder is characterized by well-
defined, inflammatory, indurated, scaly plaques generally
occurring on extensor surfaces and in most cases on the
scalp. Typically, the lesions wax and wane over the years.
Based on the clinical aspects of the lesions, seven different
subtypes have been defined (Krueger and Duvic, 1994).
Plaque psoriasis is the most common type, accounting for
more than 80% of all psoriasis cases. Although the prognosis
is rarely fatal, psoriasis has a significant adverse effect on
patients’ quality of life (Krueger et al., 2001). The impact for
health care and cost are considerable (Elder et al., 2001).
Psoriasis is a multifactorial disease arising through a
combination of both environmental and genetic risk factors,
which have been extensively documented (Bhalerao and
Bowcock, 1998; Camp, 1998). Segregation analyses of
families from large epidemiological studies show no clear
pattern of inheritance (Pietrzyk et al., 1982). The estimated
sibling-recurrence risk ratio ls ranges from 4 to 11.5
(Hellgren, 1967; Farber et al., 1974). Disease concordance
rates are much higher in monozygotic twins (65–72%) than in
dizygotic twins (15–30%), consistent with genetic factors
playing a significant part in disease pathogenesis (Bhalerao
and Bowcock, 1998).
All genome-wide studies have revealed highly significant
linkage to a region on the major histocompatibility complex
(MHC) at 6p21.3, referred to as PSORS1 (psoriasis suscepti-
bility 1, Nair et al., 1997; Trembath et al., 1997; Leder et al.,
1998; Samuelsson et al., 1999, Enlund et al., 1999a; Veal
et al., 2001; Zhang et al., 2002; Sagoo et al., 2004). Allele
sharing between sib-pairs estimated the contribution to the
familial clustering of disease (l) to be 33olo50% (Trembath
et al., 1997; The International Psoriasis Genetics Consortium,
2003). Therefore, although linkage to PSORS1 is the strongest
and most replicable, this locus does not explain the entire
genetic predisposition and several genome-wide scans have
been conducted in the search for additional psoriasis
susceptibility loci. Seven additional susceptibility loci have
been identified, namely PSORS2 to PSORS7 and PSORS9,
respectively, on chromosomes 17q25 (Tomfohrde et al.,
1994), 4q34 (Matthews et al., 1996; Nair et al., 1997), 1q21
(Capon et al., 1999), 3q21 (Enlund et al., 1999b), 19p13
(Lee et al., 2000), 1p32 (Veal et al., 2001), and 4q31 (Zhang
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et al., 2002). Suggestive linkages have also been found on
chromosomes 2q, 8q24, 20p13 (Nair et al., 1997; Trembath
et al., 1997), 16q23 (Karason et al., 2003), 3p21–23, 4q13,
5q31, 15q11 (Samuelsson et al., 1999), 21q11–q21 (Lee
et al., 2000), 2p12–p14, 7, 14q22–q32 (Veal et al., 2001),
9q33 (Zhang et al., 2002), and 18p11 (Asumalahti et al.,
2003). More recently, a meta-analysis was conducted of the
previous linkage scans for psoriasis susceptibility loci (Sagoo
et al., 2004). Apart from the major susceptibility locus
PSORS1, only PSORS2 (Tomfohrde et al., 1994; Nair et al.,
1997; Samuelsson et al., 1999; Zheng et al., 2003), PSORS3
(Matthews et al., 1996; Nair et al., 1997), PSORS6 (Lee et al.,
2000; Veal et al., 2001), PSORS4 (Capon et al., 2001), and
the regions 3q21 (Samuelsson et al., 1999), 5q31 (Friberg
et al., 2006), 16q12–q23 (Nair et al., 1997; Karason et al.,
2003), and 20p13 (Nair et al., 1997; Trembath et al., 1997)
have been detected in at least two studies.
Here we present the results of a linkage analysis performed
on extended families collected in France. As a first step, a
genome-wide scan with markers every 15 cM was carried out
on 14 multigenerational kindreds. A higher density of
microsatellite markers was used at some candidate loci
reported in the literature. All markers suggesting linkage
(Po0.01) were then tested in a second set of 32 extended
families. Our results confirm previous findings of linkage to
PSORS1 and support the presence of a susceptibility locus on
chromosome 20p13, a region previously thought to be
involved in the predisposition to psoriasis (Nair et al., 1997;
Trembath et al., 1997) and other inflammatory disorders such
as atopic dermatitis (AD) and asthma (Cookson et al., 2001).
RESULTS
A genome-wide scan was conducted in a first set of 14
multigenerational psoriasis families (Table 1). Additional
microsatellites were added to the 15 cM linkage panel at
some previously published candidate loci (Table S1). Multi-
point linkage analysis using the maximum likelihood
binomial (MLB) method allowed detection of linkage with
Pp0.001, at PSORS1 locus on 6p21 (maximum ZMLB
score¼ 3.6, P¼ 0.0002) and on chromosome 20p13 (maxi-
mum ZMLB score¼ 3.1, P¼ 0.001). In addition, we found
indication of linkage (with Po0.01) to chromosomes 10q,
13q, 14q, and 16p (Table 2). To further characterize the
linkage signal, a second set of 32 large families was
genotyped at these six loci for a replication study. The
structure of the families and the clinical characteristics of the
patients of the two sets are summarized in Table 1 and are
similar in the two groups. Furthermore, the distributions of
affected sibships, presented in Table S2, do not differ in the
two sets.
In set 2, the strongest indication of linkage was obtained at
the PSORS1 locus (ZMLB score¼ 1.5, P¼ 0.06), but the
suggested linkage to the 10q, 13q, 14q, and 20p regions in
set 1 was not confirmed. However, analyses of the pooled
samples confirmed linkage to both 6p21 and 20p13 (ZMLB
score¼ 3.5, P¼0.0002; and ZMLB score¼ 2.9, P¼0.002,
Table 2).
Second, we investigated the presence of interactions or
genetic heterogeneity between regions retained as being
potentially linked to psoriasis in the whole sample. We found
no significant correlation between the max ZMLB scores
obtained in the six detected regions (6p21, 10q, 13q, 14q,
16p, and 20p13), when these were analyzed two by two.
Similarly, the conditional MLB analyses did not reveal any
significant interaction or heterogeneity between markers of
the detected regions, including the 6p21 (data not shown).
DISCUSSION
In this study, the regions 6p21, 10q, 13q, 14q, 16p, and
20p13 were detected as susceptibility loci in a first set of 14
Table 1. Clinical characteristics of the 46 psoriasis families
Set 1 Set 2 Total
Number of families 14 32 46
Number of affected individuals 163 205 368
Male/female ratio of affected 1.01 0.93 0.97
Total family members (genotyped) 556 (466) 618 (540) 1174 (1006)
Consanguineous family — 1 1
Two-generation families — 7 7
Three-generation families 10 23 33
Four-generation families 4 1 5
Mean number of affected by family 11.6 6.4 8.0
Mean/median age of onset 19.9/14.0 19.3/12.7 19.5/13.3
Mean/median age at examination 41.9/18.5 43.3/17.6 42.7/18.0
Patients with plaque psoriasis (%) 97 95 96
Confirmation of the diagnosis by an independent physician (%) 79.9 70.2 74.7
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psoriasis families. Despite the absence or weak replication in
a second set of 32 families, the results in the whole sample set
for the 6p21 and 20p13 regions, which showed the highest
ZMLB scores, remained unchanged when compared with
those in the first set of data. The fact that the second set of
families does not provide evidence for linkage when
analyzed on its own may be because of a false detection of
linkage in the first set owing to multiple testing or to
heterogeneity between samples, which however was non-
significant when tested in the predivided sample set (data not
shown). Note that this test, as all tests of heterogeneity, is not
very powerful. The lack of replication may be also due to the
complexity of the disease depending on numerous genes with
major genetic heterogeneity; different genes would then be
detected from one study to another. Finally, it may simply be
because of a lack of power of replication due to the
variability of the statistic as has been shown for the Maximum
Lod Score statistic (Clerget-Darpoux et al., 2001).
Those loci that have been identified as potentially
involved in psoriasis susceptibility in only one or two studies
but are not picked up in other studies may be false positives,
be peculiar to the population used, or other studies may just
lack the power to detect them. It has also been shown that
some of these loci are linked to a particular subphenotype of
psoriasis. For example, the 16q locus was recently shown to
be a ‘‘psoriasis arthritis’’ locus in the Iceland study (Karason
et al., 2005). In this study, more than 95% of patients suffer
from plaque psoriasis, and there was no evidence of linkage
at the 16q locus.
Another possible reason for the lack of replication of some
results could be the large effect of the PSORS1 locus masking
the other loci involved in psoriasis. Because of this potentially
strong effect, it has been suggested that studies should
condition on the effect of the PSORS1 locus. This was carried
out here by using the conditional MLB method, which,
however, did not lead to significant increase of linkage score
when conditioning on PSORS1 in any regions detected by the
previous linkage analyses. Moreover, neither interaction nor
heterogeneity was shown here between any of these regions.
For linkage analysis the pedigrees were broken into
nuclear families because of facility of computing, and we
chose the MLB method because it uses simultaneous
information on the entire set of affected sibships. Moreover,
for complex diseases depending on numerous genes and
using an outbred population, it may be more appropriate to
use small familial structures such as nuclear families rather
than large pedigrees (Abel et al., 1998). When analyzing
whole pedigrees, the power to detect linkage may be
decreased by genetic heterogeneity within pedigrees. How-
ever, for the regions 6p and 20p, for which linkage to
Table 2. Multipoint linkage analysis (performed with MLB and MERLIN programs)
ZMLB score (P-value) ZMERLIN score (P-value)
Region Marker Distance from pter. (cM) Set 1 Set 2 Set 1+Set 2 Set 1+Set 2
6p D6S1542 47.7 3.4 (0.0003) 1.5 () 3.5 (0.0002) 1.31 ()
D6S1568 47.7 3.4 (0.0003) 1.5 () 3.5 (0.0002) 1.49 ()
TNFa 47.7 2.9 (0.002) 1.3 () 3.0 (0.001) 1.31 ()
D6S1560 47.7 2.9 (0.002) 1.1 () 2.8 (0.003) 1.31 ()
D6S1618 47.7 3.1 (0.001) 1.0 () 3.0 (0.003) 1.31 ()
D6S439 48.2 3.6 (0.0002) 0.8 () 3.2 (0.0007) 1.24 ()
10q D10S603 124 0.7 () 1.1 () 1.3 () 1.70 (0.04)
D10S1731 134 2.3 (0.01) 0.4 () 1.9 (0.03) 2.20 (0.01)
D10S587 148 0.3 () 0.3 () 0.4 () 0.65 ()
13q D13S154 75 1.2 () 0.6 () 1.3 () 0.37 ()
D13S280 85 2.9 (0.002) 0.5 () 2.4 (0.008) 1.65 (0.05)
D13S286 94 1.2 () 1.2 () 1.7 (0.04) 1.10 ()
14q D14S63 69 1.6 (0.05) 0.0 () 1.1 () 1.06 ()
D14S1028 81 2.3 (0.01) 0.0 () 1.6 (0.05) 1.20 ()
D14S1052 94 1.7 (0.04) 0.0 () 0.5 () 0.02 ()
16p D16S423 10 1.0 () 0.0 () 0.2 () 0.14 ()
D16S3075 23 2.4 (0.008) 0.8 () 2.3 (0.01) 0.67 ()
D16S3103 32 1.7 (0.04) 0.6 () 1.6 (0.05) 0.92 ()
20p D20S864 0 3.1 (0.001) 0.9 () 2.9 (0.002) 1.62 (0.05)
D20S116 11 2.8 (0.003) 0.6 () 2.4 (0.008) 1.48 ()
(): P40.05.
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psoriasis could be confirmed by using the MLB method on
pedigrees separated into nuclear families, we also applied the
program SIMWALK (Sobel and Lange, 1996) using the non
parametric linkage (NPL) statistic on the whole pedigrees,
because this program makes it possible to analyze pedigrees
as large as those present in our sample. With this analysis,
there was weak indication of linkage to the 6p region and
there was no indication of linkage to the 20p region (data not
shown).
In addition, we also performed NPL analyses using the
affected sib-pairs (ASP) method implemented in MERLIN
(Abecasis et al., 2002). Families were too large to perform
multipoint linkage analyses on the whole pedigrees using this
program, and they too had to be cut into nuclear families. No
significant linkage was detected with this method on any
chromosome. Results obtained with MERLIN for the regions
6p21, 10q, 13q, 14q, 16p, and 20p13 are presented in
Table 2. Apart from locus on chromosome 10q, the NPL
statistic generated by MERLIN suggested weaker linkage
signals than the ZMLB scores. The power to detect linkage
depends on the informativity of the data including the familial
structures of the pedigrees. In particular, for the MLB method,
this informativity depends mostly on the number and size of
the affected sibships present in the sample. Thus, the loss of
power with MERLIN may be attributable to the fact that this
program cannot use simultaneous information on the entire
set of affected sibships as does the MLB method. Therefore,
the MLB method seems more appropriate here, as there were
extended affected sibships in the pedigrees included in this
study.
The number of genes involved in the pathogenesis of
psoriasis and their chromosomal location are presently
unknown and only the MHC region (PSORS1 locus) has
met the accepted criteria for genome-wide significance and
has been consistently replicated in independent studies (Elder
et al., 2001). Refinement of the interval using single-
nucleotide polymorphisms (SNPs) has been carried out by
several teams, and associations between psoriasis and SNPs
have been reported without clear identification of a gene in
which mutations or polymorphisms could explain the
disorders, although some alleles in the MHC region are good
candidates, particularly human leukocyte antigen (HLA)-
Cw0602 (Jenisch et al., 1998; Balendran et al., 1999;
Oka et al., 1999; Nair et al., 2000; Helms et al., 2005; Holm
et al., 2005). Association between HCR*WWCC (Asumalahti
et al., 2000, 2002) and CDSN*5 (Ishihara et al., 1996;
Allen et al., 1999; Jenisch et al., 1999; Capon et al., 2004;
Lench et al., 2005; Chang et al., 2006) in strong linkage
disequilibrium with (HLA)-Cw0602, and psoriasis has also
been demonstrated. We also confirmed the associations with
these three tightly linked susceptibility alleles and psoriasis in
our family set (data not shown). Based on the linkage and
association studies, the PSORS1 locus seems to explain
30–50% of psoriasis susceptibility. Other minor susceptibility
loci are thus likely to exist. The detection of the minor loci
has, however, proved to be difficult because of locus
heterogeneity, which makes the replication of the linkage
difficult in different ethnic groups (Capon et al., 2002).
The 10q region has been reported previously in a meta-
analysis performed on six psoriasis genome-wide scans
(Sagoo et al., 2004), but in our study ZMLB score did not
reach a significant value when analyzing the whole sample.
Although showing weaker linkage in this study, the 13q and
14q regions have been reported to be linked to psoriasis (Veal
et al., 2001; Sagoo et al., 2004). However, for replication
studies of published regions, thresholds for the detection of
linkage may be less stringent. The 16p region, which has not
been reported elsewhere, is of borderline significance and
could be a false positive result or be peculiar to the French
population used. To conclude, the most significant non-MHC
locus in French patients was on chromosome 20p. Our
finding is reinforced by the implication of this region in two
other independent genome-wide studies. The first one was
carried out on 41 multiplex European families (Trembath
et al., 1997) and the second on 115 American and German
families (Nair et al., 1997).
A genetic component to autoimmune susceptibility has
been clearly shown by twin and adoption studies and by
increased risk to siblings (Vyse and Todd, 1996). The 20p
locus was not found initially among the non-MHC loci that
could collectively contribute to disease susceptibility in
human autoimmune diseases (Becker et al., 1998), but it is
also of note that a linkage to this locus has been found
afterwards in a genome screen for childhood AD (Cookson
et al., 2001). Although immunologic processes of psoriasis
and AD are quite different (psoriasis is TH-1 mediated and
AD is a TH-2 reaction), both diseases are characterized by
dry, scaly skin, disturbed epidermal differentiation, and an
inflammation that is responsive to T-cell-specific agents. The
two diseases rarely occur together in the same patient.
However, linkage of both diseases to the 20p13 locus
indicates that psoriasis and AD are influenced by genes with
general effects on cutaneous inflammation and immunity.
The 17 Mb interval on chromosome 20 contains 428
known genes. A refinement of this interval is obviously
needed before any relationship between psoriasis and a
particular gene in this region could be considered, even
though the b-defensin genes, known to be implicated in
immunologic defense against bacteria, fungi, and some
enveloped viruses (Ganz 2002; Yang et al., 2002) and
TGM3 encoding a transglutaminase, for which the transcript
is upregulated in psoriatic skin versus normal skin (Bowcock
et al., 2001), are good candidates. But there are undoubtedly
additional compelling candidates. Replication of our findings
is necessary and linkage disequilibrium studies using SNPs
across this interval for positional cloning may ultimately
identify the causative gene.
MATERIALS AND METHODS
Families
Families with psoriasis were recruited through a media campaign
between 1996 and 2001 at Ge´ne´thon, using posters in the Paris
Me´tro and information in news magazines, radio, and television
(Mahe´ et al., 2002). From 50,000 phone calls received by a toll-free
telephone number, 108 families with at least eight putative affected
members were identified, most of them with an apparent autosomal
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dominant mode of inheritance of psoriasis. Clinical diagnoses were
checked by systematic telephone calls to every family member,
affected or non-affected, for each family, at least twice during
4 years by dermatologists using a standard questionnaire available
on request. The attending physician of each patient was also
contacted, mainly by mail, which led to confirmation of the
diagnosis in over 75% of cases. Material was available for 46
families from France. They were split into two sets to reduce the
genotyping effort. The structure of the 46 families and the clinical
characteristics of the patients are summarized in Table 1. This study
was approved by the Ethics Committee of Le Kremlin-Biceˆtre
Hospital in 1995 (CCPPRB). All subjects participating in this study
provided informed consent. The study was conducted in concor-
dance with the Declaration of Helsinki Principles.
Genotyping
DNA was extracted from whole blood using the standard phenol/
chloroform procedure. A genome-wide scan using 260 polymorphic
microsatellite markers from Ge´ne´thon (Evry, France) was carried out
as described previously (Dib et al., 1996). The marker map position
was based on the Marshfield map (http://research.marshfieldclinic.
org/genetics/GeneticResearch/compMaps.asp). Markers were spaced
at an average distance of 15 cM. When suggestive linkage was found
in the first set of 14 families, the locus was analyzed in the second set
using 2–6 adjacent microsatellite markers with the exception of the
6p21 region (13 markers) and the 8q24 region (nine markers). The
characteristics of these markers are described in Table S1.
Linkage analysis
Because of their large size, the complete pedigrees could not
be analyzed by the computer programs currently used for linkage
analysis, such as GENEHUNTER (Kruglyak et al., 1996),
Allegro (Gudbjartsson et al., 2000), or MERLIN (Abecasis et al.,
2002), which have shown to be comparable (Abecasis et al., 2002;
Dudbridge, 2003). Other programs such as LINKAGE (Lathrop et al.,
1984) and SIMWALK (Sobel and Lange, 1996) could be used,
but only for a limited number of markers or using a very long
computing time.
When using the MLB method (Majumder and Pal, 1987, Satsangi
et al., 1996, Abel and Muller-Myhsok, 1998) or MERLIN, the
pedigrees were therefore broken into nuclear families using the
Mega2 program (Mukhopadhyay et al., 2005). The first set of 14
pedigrees and the second set of 32 pedigrees produced 32 and 45
nuclear families, respectively, each with at least two affected sibs,
which were used for linkage analyses. The distribution of sibships
according to the number of affected sibs for each set of the 46
pedigrees is shown in Table S2.
Multipoint NPL analyses were performed on the ASP using
MERLIN (Abecasis et al., 2002). The ASP method calculates
inheritance distribution for sets of affected pairs and then uses a
score function to determine significance of linkage. We used the
NPLAll statistic, which estimates identical-by-descent allele sharing
among all affected members and is averaged over all possible
inheritance patterns, normalized, and weighted across pedigrees.
Under the null hypothesis of no linkage, the NPL statistic is
distributed asymptotically as a standard normal random variable.
Results are reported in terms of an NPL Z score (ZMERLIN) and its
associated one-sided P-value.
Because most of the pedigrees included in this study were
complicated and their information may not be fully utilized by the
NPL statistics, we applied another multipoint analysis using the MLB
model-free method (Majumder and Pal, 1987; Satsangi et al., 1996;
Abel and Muller-Myhsok, 1998); this method does not require
specification of the underlying genetic model for the trait investi-
gated, and has the additional advantage of being applicable to
complete sibships of affected individuals. The principle of the
method is based on the binomial distribution of the number of
affected sibs receiving a given parental allele. The likelihood
contribution for meioses from a heterozygous parent with n affected
offspring of which m inherited one marker allele and nm the other
is equal to [am(1a)vmþ avm(1a)m]. For the whole family, the
contribution is the product of the two parental contributions. The
product of the likelihoods over all families is maximised over a, with
a being the probability for an affected sib to receive the marker allele
transmitted with the disease allele. The test for linkage is performed
using a likelihood ratio test statistic, L¼ 2 Ln[L(a)/L(a¼ 0.5)], with a
being equal to 0.5 under the null hypothesis of no linkage and
a40.5 under the hypothesis of linkage. The statistic L is distributed
asymptotically as a mixture distribution of 0.5 w20df and 0.5 w
2
1df, and
ZMLB¼L0.5 is a one-sided standard normal deviate. All these
analyses were conducted using the multipoint approach with the
program MLBGH (Abel et al., 1998). Allelic frequencies of the
markers were estimated from the founders and unrelated individuals
from pedigrees.
Results from the different data sets and for the whole sample were
not corrected for multiple testing. It is known that correction for
multiple testing of a genome scan is generally difficult to apply.
A simple correction of Bonferroni type according to the total number
of analyzed markers is conservative, because of linkage between the
markers, particularly when the mapping was very fine in some
regions, which is the case in our study. The linkage thresholds as
proposed by Lander and Kruglyak (1995) are also conservative, as
they have been computed under the assumption of a complete dense
genome map.
Two loci and heterogeneity model analysis
Correlations between ZMLB scores of loci with the maximum scores
in the regions detected by previous linkage analyses were computed.
In the case of significant correlation, linkage analysis with the MLB
method at one of the loci was performed conditionally to the other
locus, following a similar approach to the one developed by Cox
et al. (1999) using the NPL score. Conditional linkage analysis was
performed by setting a weight of 1 to the families with a ZMLB score
40 at the second locus and a weight of 0 to families with a ZMLB
score¼ 0 in the case of positive correlation (interaction model).
Conversely, a weight of 0 was assigned to families with a ZMLB score
40 and a weight of 1 to the other families in the case of negative
correlation (heterogeneity model). Absence of interaction or of
heterogeneity is tested by measuring the significance of the increase
of the MLB score using the non-conditional versus the conditional
approach, the difference between the (ZMLB)
2 following asymptoti-
cally a w2 test with 1 df (Figure 1).
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